Compound sulfamethoxazole for pediatric pertussis: a retrospective cohort study in a region with high macrolide resistance
SMZco significantly improves treatment effectiveness, shortens symptom duration and hospitalization, and reduces economic burden in pediatric pertussis. These findings position SMZco as an effective and safe alternative, particularly in regions with high macrolide resistance.
Authors
- Mingying Wang
- Xiao Liu (ORCID: https://orcid.org/0000-0002-8459-3135)
- Ting Xie (ORCID: https://orcid.org/0000-0002-9958-3888)
- Yaping Su (ORCID: https://orcid.org/0000-0002-8865-1806)
- Ying Zhong (ORCID: https://orcid.org/0000-0002-8498-1373)
- Lin Li (ORCID: https://orcid.org/0000-0002-8014-8296)
Institutions
- Zigong First People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Pediatrics
- Published
- 2025-12-09
- DOI
- https://doi.org/10.3389/fped.2025.1622467
- Primary Topic
- Bacterial Infections and Vaccines
- Type
- article
- Field-Weighted Citation Impact
- 0.00